Sentences with phrase «cell and gene therapy»

It will literally determine whether patients and physicians can realize the potential of cell and gene therapies.
Although it was not surprising for cell and gene therapies per se, the growth that we have seen in this industry has been pretty dramatic around the world as well.
Scientists used a combination of stem cells and gene therapy to repair the damage.
Only recently have cell and gene therapy begun to triumph, by borrowing from and blending into each other's approaches.
In conjunction, innovations in cell expansion media and systems are critical to overcoming the technical and manufacturing challenges facing those developing cell and gene therapies.
In a last - ditch effort to save a dying 7 - year - old boy, scientists have used stem cells and gene therapy to replace about 80 percent of his skin.
Researchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist have developed an alternative treatment in which virus - specific cells protect patients against severe, drug - resistant viral infections.
Over the past six years, my research has focused more heavily on the non-human primate as a model system for examining mechanisms of retinal disease and development and evaluation of prospective cell and gene therapies in this model.
Experts in pediatric oncology, pediatric surgery, cell and gene therapy including stem cell transplant, radiation oncology, pediatric anesthesia, pharmacology, social work, child life and the full complement of pediatric subspecialty services put a strong focus on family - centered care and emotional support for both the child and the family.
In August, he will be the keynote speaker at the third Conference on Cell and Gene Therapy for HIV cure at Fred Hutch about an even more challenging goal: an HIV cure.
At the January 2016 Phacilitate Cell and Gene Therapy World conference, Siddharth Gupta, a scientist at Lonza (Walkersville, MD), talked about the effects of upstream process decisions on product quality in his presentation «Bioreactor Manufacturing Platforms: So...
A new large - scale cell and gene therapy manufacturing centre is scheduled to open in early 2018 in Stevenage, Hertfordshire.
A team led by Shoukhrat Mitalipov, Ph.D., director of the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University, has discovered that induced pluripotent stem, or iPS, cells, a type of stem cell derived from patients» skin or blood cells contain faulty mitochondrial DNA.
The complexity of the development of cells and gene therapy products are addressed by designing tailored studies to allow safety assessment of GTMPs and to fulfil GLP requirements and OECD principles.
Video: Courtesy of Cell and Gene Therapy Catapult
StemFit cell culture media has been independently evaluated by CGT Catapult, an independent centre of excellence helping advance the UK cell and gene therapy industry.
From 1997 to 2003, he served as St. Jude's medical director of cell and gene therapy laboratories.
Dr. Levine directs the Clinical Cell and Vaccine Production Facility (CVPF), which develops, manufactures, and tests novel cell and gene therapies in clinical trials at Penn and collaborating institutions.
Phacilitate and Cell and Gene Therapy Insights have teamed up to further support collaboration between academic and industry pioneers.
Account Executive ➤ Clinical Applications Specialist ➤ Cell and Gene Therapy ➤ Biotechnology and Pharmaceuticals
Clinical Pharmacology Research Track Neuro - oncology Clinical Research Track Cell and Gene Therapy Clinical Research Track Leukemia Clinical Research Track Solid Tumor Clinical Research Track
During the congress» Innovation Summit - Retinal cell and Gene Therapy» in Seattle on April 28th and 29th, 2016, in the margins of the meeting ARVO, Christelle Monville, Professor at the» Université d'Evry Val d'Essonne» (UEVE), presented the advances of the cell therapy program» STREAM» (Stem cell Therapy for Retinal Epithelium replacement Assay in Monogenic retinopathies) led by her team in I - Stem.
• Obsidian Therapeutics, a Cambridge, Mass. - based biotechnology developing next - generation cell and gene therapies, raised $ 49.5 million in Series A funding led by GV, and was joined by investors including Atlas Venture, Takeda Ventures Inc., Vertex Ventures HC, Amgen Ventures, Alexandria Venture Investments, and ShangPharma Investment Group.
• Vineti, a San Francisco - based cell and gene therapy software and analytics company, raised $ 13.75 million in Series A funding.
The overarching trend right now in bioprocessing and pharmaceuticals is essentially the shift from small molecules and biologics to now cell and gene therapies.
Our multidisciplinary team of experts in pediatric oncology, surgery, pharmacology, stem cell transplant, molecular oncology, and cell and gene therapy works together to research and provide new means of diagnosing, monitoring, treating, preventing as well as predicting the behavior of lymphoma.
The World Stem Cell Summit will be co-located for the first time with the # 1 global industry event the Phacilitate Leadership Forum Cell and Gene Therapy World, Immuno - Oncology Frontiers World, and Cord Blood and Perinatal Stem Cells.
We made history in August 2017 when the FDA approved a personalized cell therapy for advanced leukemia, the first - ever for cancer cell and gene therapy.
Pioneering CAR T - cell therapy researcher Dr. Carl June, director of the Center for Cellular Immunotherapies at the University of Pennsylvania's Perelman School of Medicine and a co-director of the Parker Institute for Cancer Immunotherapy, delivered the keynote address at the Conference on Cell and Gene Therapy for HIV Cure at Fred Hutch.
Mitalipov is director of the Center for Embryonic Cell and Gene Therapy at OHSU.
Supported by: Hear from leading expert Dr David DiGiusto, Stanford University School of Medicine, USA, as he shares his extensive experience in developing and optimizing manufacturing processes for cell and gene therapy products including:
In this podcast and accompanying article, we interviewed Ricardo Baptista, Lead Process Development Scientist, Cell and Gene Therapy Catapult, UK about his impressions on current bioprocessing technologies for stem cell...
Chris is Senior Editor of the journals; «Cell and Gene Therapy Insight» and «Regenerative Medicine».
At the Center for Cell and Gene Therapy at Baylor College of Medicine in Houston, director Malcolm Brenner, a geneticist, says he has turned «AdV from poacher into gamekeeper.»
But it may be many more years before off - the - shelf T - cells created with gene editing get approval, says Usman Azam, head of cell and gene therapies at Novartis.
Looking ahead, Gordon stresses that researchers will continue to pursue other therapeutic strategies, including stem cells and gene therapy, for which the mouse model will be critical.
«In this study we continued our previous work in the Center for Cell and Gene Therapy, in which we showed that patients who had developed an Epstein - Barr virus infection after a transplant that led to a lymphoproliferative disease, could be helped by receiving immune cells specialized in eliminating that particular virus,» said first author Dr. Ifigeneia Tzannou, instructor of medicine in the section of hematology and oncology at Baylor College of Medicine.
Jonathan Appleby, GSK project leader for the ADA - SCID trial and head of cell and gene therapy at the rare diseases unit, says there are many differences between working on this kind of trial and working with one for a common disease.
This work was supported by the Max - Planck - Society, the German Research Council (DFG), the Excellence Cluster Cardiopulmonary System (ECCPS), the University of Giessen - Marburg Lung Center (UGMLC), the Cell and Gene Therapy Center (CGT) of the University of Frankfurt and the EY10540 grant to PAT.
While in Boston for the 2018 BIO International Convention, join ARM for a private evening reception bringing together key stakeholders representing the cell and gene therapy sector.
His work also contributed to advance the use of artificial nucleases for targeted genome editing in cell and gene therapy.
He is a general spokesperson for the cell and gene therapy sector including frequent newspaper, radio and TV interviews.
First hand experience of implementing automated solutions across the cell and gene therapy manufacturing pathway.
The remainder of the webinar is a Q&A session with both Dr DiGiusto and Dr Schlinker sharing their perspective on the critical issues around manufacture of cell and gene therapies.
This is followed by a presentation by Dr Alaina Schlinker, Fresenius Kabi, as she discusses practical approaches to addressing some of the key processing challenges for cell and gene therapy products.
The meeting of the Genomics Advisory Committee will take place alongside those of seven other Advisory Committees focussed on the respective issues of Cell and Gene Therapy, Engineering Biology, Finance and Tax, Intellectual Property, Manufacturing, Regulatory Affairs and Science and Innovation.
a b c d e f g h i j k l m n o p q r s t u v w x y z